1-8 of 8
Jana L Dawson, BS
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Combination Therapy with Bortezomib or Carfilzomib and Selinexor Induces Nuclear Localization of Ikbα and Overcomes Acquired Proteasome Inhibitor Resistance in Human Multiple Myeloma

Free
Joel G Turner, PhD, Trinayan Kashyap, MS, Jana L Dawson, BS, Juan A Gomez, BS, Alexis Bauer, BS, Steven Grant, MD, Yun Dai, PhD, Kenneth H. Shain, MD PhD, Mark B Meads, PhD, Yosef Landesman, PhD, Daniel M Sullivan, MD
Journal: Blood
Blood (2016) 128 (22): 3299.
https://doi.org/10.1182/blood.V128.22.3299.3299
Published: 2016
Journal Articles

The Synergistic Effect of Melphalan and XPO1 Inhibition in Pre-Clinical Models of Multiple Myeloma

Free
Yan Cui, MD, Joel G Turner, PhD, Jana L Dawson, BS, Juan A Gomez, BS, Kenneth H. Shain, MD PhD, Mark B Meads, PhD, Erkan Baloglu, PhD, William S. Dalton, PhD MD, Taiga Nishihori, MD, Daniel M Sullivan, MD
Journal: Blood
Blood (2016) 128 (22): 5662.
https://doi.org/10.1182/blood.V128.22.5662.5662
Published: 2016
Journal Articles

Combination Therapy of Selinexor with Bortezomib or Carfilzomib Overcomes Drug Resistance to Proteasome Inhibitors (PI) in Human Multiple Myeloma

Free
Daniel M Sullivan, MD, Trinayan Kashyap, MS, Jana L Dawson, BS, Yosef Landesman, PhD, Steven Grant, MD, Kenneth H. Shain, MD PhD, Yun Dai, PhD, Michael Kauffman, MD PhD, Sharon Shacham, Joel G Turner, PhD
Journal: Blood
Blood (2015) 126 (23): 3048.
https://doi.org/10.1182/blood.V126.23.3048.3048
Published: 2015
Journal Articles

Next Generation XPO1 Inhibitor KPT-8602 for the Treatment of Drug-Resistant Multiple Myeloma

Free
Joel G Turner, PhD, Jana L Dawson, BS, Christopher L Cubitt, PhD, Erkan Baluglo, PhD, Steven Grant, MD, Yun Dai, PhD, Kenneth H Shain, MD PhD, William S. Dalton, PhD MD, Sharon Shacham, William Senapedis, PhD, Daniel M Sullivan, MD
Journal: Blood
Blood (2015) 126 (23): 1818.
https://doi.org/10.1182/blood.V126.23.1818.1818
Published: 2015
Journal Articles

Melphalan and XPO1 Inhibitor Combination Therapy for the Treatment of Multiple Myeloma

Free
Joel G Turner, PhD, Jana L Dawson, BS, Steven Grant, MD, Kenneth H. Shain, MD PhD, Yun Dai, MD PhD, Chris Cubitt, PhD, Rachid Baz, MD, Taiga Nishihori, MD, Michael Kauffman, MD PhD, Sharon Shacham, PhD MBA, Daniel M Sullivan, MD
Journal: Blood
Blood (2014) 124 (21): 2084.
https://doi.org/10.1182/blood.V124.21.2084.2084
Published: 2014
Journal Articles

Targeting The Nuclear Export Signal In Multiple Myeloma

Free
Joel G Turner, PhD, Thomas C Rowe, PhD, David Ostrov, PhD, Jana L Dawson, BS, Danielle Pernazza, PhD, Nicholas J Lawrence, Ph.D., Daniel M Sullivan, MD
Journal: Blood
Blood (2013) 122 (21): 1925.
https://doi.org/10.1182/blood.V122.21.1925.1925
Published: 2013
Journal Articles

Casein Kinase II Modulates Topoisomerase II Alpha Nuclear Export and Drug Sensitivity in Multiple Myeloma

Free
Joel G Turner, PhD, Jana L Dawson, BS, Daniel M Sullivan, MD
Journal: Blood
Blood (2012) 120 (21): 4032.
https://doi.org/10.1182/blood.V120.21.4032.4032
Published: 2012
Journal Articles

Novel Drug Targets to Overcome De Novo Drug-Resistance In Multiple Myeloma

Free
Joel G Turner, PhD, Thomas C Rowe, PhD, David Ostrov, Jana L Dawson, BS, Elizabeth Ciaravino, BS, Daniel Sullivan, MD
Journal: Blood
Blood (2010) 116 (21): 3006.
https://doi.org/10.1182/blood.V116.21.3006.3006
Published: 2010